STELARA® Phase 3 Data - Treatment for Ulcerative Colitis
Dr. Bruce Sands from Mount Sinai discusses his presentation of the new pivotal Phase 3 data at the American College of Gastroenterology (ACG) Annual Scientific Meeting showing that a single IV dose of STELARA® (ustekinumab) – the first and only biologic targeting interleukin (IL)-12 and -23 cytokines – induced clinical remission in a greater percentage of adult patients with moderate-to-severe ulcerative colitis (UC), compared to those receiving placebo.
Visit www.hpr.fm for more health-related stories, news, and research updates.
Видео STELARA® Phase 3 Data - Treatment for Ulcerative Colitis канала HPR
Visit www.hpr.fm for more health-related stories, news, and research updates.
Видео STELARA® Phase 3 Data - Treatment for Ulcerative Colitis канала HPR
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Summer Allergy SeasonNeuromyelitis Optica Spectrum Disorder (NMOSD)Karuna Therapeutics - Trial Evaluating KarXT in SchizophreniaVirtual Technology for Chronic Pain and Movement Disorders ReliefCytomX Therapeutics - Next Generation of Cancer TreatmentsAGTC - Genetic Therapy For Rare DiseasesPharmaEssentia - Applying the Power of Interferon to Treat Cancers DifferentlySpinal Muscular Atrophy (SMA) Awareness - Patient Treated with EvrysdiThe FDA’s "Project Optimus" and Oncology DrugsViiV Healthcare - Innovation in HIV CareAmerican Academy of Pediatrics New Book on Puberty for Ages 9-13 and ParentsUnderstanding the Best Practices to Set Up an Infusion ClinicBiotricity - AI in the Future of Wearable Heart Monitoring DevicesACTRIMS 2022 - Clinical Trial Design and the Use of Novel Patient Recruitment Strategy ACTRIMS 2022Oyster Point Pharma - Novel Treatment Option for Dry Eye DiseaseNew Insights on Sepsis Risk Post-UreteroscopyQIAGEN - More Than Three Billion Biological Samples TestedNuminus Completes First MDMA Administration in PTSD TrialLyell Immunopharma - Cell Therapy and Solid Tumor CancersHalia Therapeutics – Eliminating Chronic Inflammation by Targeting the NLRP3 InflammasomeThe Role of Practitioner-Led Nutrition Advice in Supporting Mother During Pregnancy for Best Outcome